• Policy
• The first COVID-19 vaccine is expected to be approved
• by Lee, Hye-Kyung Jun 28, 2022 06:09am

• Policy
• Fenofibrate regardless of meals will be listed next month
• by Lee, Tak-Sun Jun 28, 2022 06:09am

• Policy
• The use of Benzalconium chloride is not interrupted
• by Lee, Hye-Kyung Jun 27, 2022 05:58am

• Policy
• Is "Platform of Drug Delivery" starting?
• by Lee, Jeong-Hwan Jun 24, 2022 05:46am

• Policy
• A suspected Monkeypox patient entered Korea
• by Lee, Jeong-Hwan Jun 24, 2022 05:46am

• Policy
• Abnormal cases of Inlyta in PMS for 9 yrs is 82.8%
• by Lee, Hye-Kyung Jun 24, 2022 05:45am

• Policy
• Kadcyla to recieve reimb in early breast cancer from July
• by Lee, Tak-Sun Jun 22, 2022 05:59am

• Policy
• Alecensa's price cut 4.5%, Remodulin 4% due to excess sales
• by Kim, Jung-Ju Jun 22, 2022 05:59am

• Policy
• The benefit discussion for Steglatro was excluded
• by Lee, Tak-Sun Jun 22, 2022 05:58am

• Policy
• Report of severe skin SE such as rash of Phenytoin
• by Lee, Hye-Kyung Jun 21, 2022 05:55am